SOA Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1
Closed -$30 942
2023
Q1
$30 Hold
1
﹤0.01% 956
2022
Q4
$27 Hold
1
﹤0.01% 962
2022
Q3
$0 Hold
1
﹤0.01% 824
2022
Q2
$0 Hold
1
﹤0.01% 815
2022
Q1
$0 Sell
1
-8
-89% -$258 ﹤0.01% 898
2021
Q4
$0 Buy
9
+1
+13% +$32 ﹤0.01% 873
2021
Q3
$0 Hold
8
﹤0.01% 890
2021
Q2
$0 Hold
8
﹤0.01% 861
2021
Q1
$0 Sell
8
-3
-27% -$141 ﹤0.01% 809
2020
Q4
$0 Buy
+11
New +$458 ﹤0.01% 789

Other funds holding AVNS

SOA Wealth Advisors's AVNS Position: Q2 2023 in Review

SOA Wealth Advisors sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 1 share — an estimated $30 sold.

SOA Wealth Advisors first reported a position in AVNS in Q4 2020 and held it in 10 quarters. The position peaked at $30 in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • SOA Wealth Advisors reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • SOA Wealth Advisors sold 1 Avanos Medical share in Q2 2023, an estimated $30.
  • SOA Wealth Advisors first reported a position in Avanos Medical in Q4 2020 and held it in 10 quarters.
  • SOA Wealth Advisors's Avanos Medical position peaked at $30 in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on SOA Wealth Advisors's 13F filing for Q2 2023, filed 7 Jul 2023.